Tamoxifen treatment of breast cancer cells : Impact on Hedgehog/GLI1 signaling

The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2016

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/21353

Acceso en línea:

https://doi.org/10.3390/ijms17030308
https://repository.urosario.edu.co/handle/10336/21353

Palabra clave:

Hormona antineoplásica
Proteína GLI1
Tamoxifeno factor de transcripcion
Factor de transcripción Gli1
Cancer de mama
Enfermedades
Sonic hedgehog protein
Transcription factor Gli1
Antineoplastic hormone agonists and antagonists
Sonic hedgehog protein
Transcription factor
Transcription factor Gli1
human
GLI1 protein
Neoplasias
Tamoxifeno

Rights

License

Abierto (Texto Completo)